114 related articles for article (PubMed ID: 36068099)
41. CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.
Touati M; Delage-Corre M; Monteil J; Abraham J; Moreau S; Remenieras L; Gourin MP; Dmytruk N; Olivrie A; Turlure P; Girault S; Labrousse F; Preux PM; Jaccard A; Bordessoule D
Leuk Lymphoma; 2015 Feb; 56(2):332-41. PubMed ID: 24766492
[TBL] [Abstract][Full Text] [Related]
42. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
43. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
[TBL] [Abstract][Full Text] [Related]
44. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].
Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465
[TBL] [Abstract][Full Text] [Related]
45. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
46. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.
Zaki MA; Wada N; Ikeda J; Shibayama H; Hashimoto K; Yamagami T; Tatsumi Y; Tsukaguchi M; Take H; Tsudo M; Morii E; Aozasa K
Virchows Arch; 2011 Oct; 459(4):361-6. PubMed ID: 21874508
[TBL] [Abstract][Full Text] [Related]
47. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
48. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma.
Karihtala K; Leivonen SK; Brück O; Karjalainen-Lindsberg ML; Mustjoki S; Pellinen T; Leppä S
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260340
[TBL] [Abstract][Full Text] [Related]
50. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792
[TBL] [Abstract][Full Text] [Related]
52. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
[TBL] [Abstract][Full Text] [Related]
53. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Value of Tumor Associated Macrophage Markers CD163 and CD68 Immunohistochemistry in Classical Hodgkin Lymphoma.
Rashed RA; Zaki MAM; Mohamed NAW; Mansou OM; Refaey FAHE
Clin Lab; 2021 May; 67(5):. PubMed ID: 33978358
[TBL] [Abstract][Full Text] [Related]
55. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
[TBL] [Abstract][Full Text] [Related]
57. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
[TBL] [Abstract][Full Text] [Related]
58. B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction.
Tudor CS; Distel LV; Eckhardt J; Hartmann A; Niedobitek G; Buettner M
Hum Pathol; 2013 Nov; 44(11):2475-86. PubMed ID: 24029709
[TBL] [Abstract][Full Text] [Related]
59. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Leary A; Genestie C; Blanc-Durand F; Gouy S; Dunant A; Maulard A; Drusch F; Cheaib B; Michels J; Bentivegna E; LeFormal A; Mesnage S; Morice P; Pautier P; Khairallah AS
Cancer Immunol Immunother; 2021 Feb; 70(2):519-531. PubMed ID: 32852603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
